Endothelial cells exposed to anoxia/reoxygenation are hyperadhesive to T-lymphocytes: kinetics and molecular mechanisms

Microcirculation. 2000 Feb;7(1):13-23.

Abstract

Objective: The objectives of this study were to 1) determine the time-course of T-lymphocyte adhesion to monolayers of human umbilical vein endothelial cell (HUVEC) that were exposed to 60 min of anoxia followed by 24 h of reoxygenation, and 2) define the mechanisms responsible for the hyperadhesivity of postanoxic HUVEC to human T-lymphocytes.

Methods: Human peripheral blood mononuclear leukocytes were isolated from heparinized peripheral blood. T-lymphocytes were obtained by negative selection using a MACS column. HUVEC monolayers were exposed to anoxia/reoxygenation (A/R), and then reacted with 51Cr -labeled T-lymphocytes in adhesion assays.

Results: A/R leads to an increased adhesion of T-lymphocytes to HUVEC monolayers, with peak responses occurring at 8 h after reoxygenation. This adhesion response was largely attributed to the CD4+ T-cell subset. The hyperadhesivity of A/R-exposed HUVEC was inhibited by monoclonal antibodies directed against either LFA-1, VLA-4, ICAM-1, or VCAM-1, indicating a contribution of these adhesion molecules and their ligands. Moreover, T-cell hyperadhesivity was attenuated by anti- IL-8. consistent with a role for this chemokine in the adhesion response. Protein synthesis inhibitors (actinomycin D and cycloheximide) as well as chemical inhibitors of (and binding ds-oligonucleotides to) NFkappaB and AP-1 significantly attenuated the A/R-induced T-lymphocyte adhesion responses. The kinetics of VCAM-1 on post-anoxic HUVEC correlated with the T-lymphocyte adhesion response.

Conclusions: A/R elicits a T-lymphocyte-endothelial cell adhesion response that involves transcription-dependent surface expression of VCAM-1.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Benzamides / pharmacology
  • Cell Adhesion
  • Cell Adhesion Molecules / immunology
  • Cell Adhesion Molecules / physiology
  • Cell Hypoxia
  • Cells, Cultured
  • Cysteine Endopeptidases / physiology
  • Endothelium, Vascular / cytology*
  • Humans
  • Interleukin-8 / antagonists & inhibitors
  • Interleukin-8 / immunology
  • Interleukin-8 / physiology
  • Ischemia / pathology*
  • Kinetics
  • Leupeptins / pharmacology
  • Multienzyme Complexes / physiology
  • NF-kappa B / antagonists & inhibitors
  • Oxygen / pharmacology
  • Proteasome Endopeptidase Complex
  • Protein Synthesis Inhibitors / pharmacology
  • Reperfusion Injury / pathology*
  • T-Lymphocyte Subsets / cytology*
  • Thionucleotides / pharmacology
  • Time Factors
  • Transcription Factor AP-1 / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology
  • Umbilical Veins
  • Vascular Cell Adhesion Molecule-1 / biosynthesis
  • Vascular Cell Adhesion Molecule-1 / physiology

Substances

  • Antibodies, Monoclonal
  • Benzamides
  • Cell Adhesion Molecules
  • Interleukin-8
  • Leupeptins
  • Multienzyme Complexes
  • NF-kappa B
  • Protein Synthesis Inhibitors
  • Thionucleotides
  • Transcription Factor AP-1
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • 3-aminobenzamide
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • Oxygen